Source: Financial Afrik Author: Ibrahima jr Dia

Professor Didier Raoult has indicated that the thesis of the dangerousness of hydroxychloroquine in the treatment of covid-19 is the greatest scientific scandal of all time. 

In a video posted on Tuesday, August 18, the Marseille infectious disease specialist stressed that scientific communications have been subject to influences and choices of very great mediocrity.

The director of the IHU Méditerranée-Infection believes that everyone should stay in their place, politicians and scientists. Politicians, he points out, make politics out of science. If these are no longer reliable then it will be a disaster. “I think it’s extremely clear, scientific journals are subject to manipulation by public decision-makers”.

In addition, the doctor revealed figures proving once again the effectiveness of hydroxychloroquine combined with azithromycin to treat the coronavirus. According to these statistics, out of a number of 184,589 tests performed, 78,994 are positive, i.e. a positivity rate of 7.6%. Among them 165 died, that is to say 2, 8%. Of 4,030 patients treated with hydroxychloroquine in combination with azithromycin, 18 died, representing a mortality rate of 0.4%. This therapeutic indication is the subject of strong criticism within the scientific community. Nonetheless, Raoult’s supporters still demand that this treatment be systematically incorporated into all clinical trials.

Related: France 24: Hydroxychloroquine effective in treating COVID-19, according to study of 2,500

Mortality 0%: A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island

Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France

France Soir – Opinion: CovidPapers, Recovery, & the Oxford Connection

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »